Primary plasma cell leukemia (pPCL) is a rare and aggressive plasma cell neoplasm, with rapidly progressing clinical course. patients. In a multivariate analysis, an elevated lactate dehydrogenase level, low albumin ( 3.5 g/dL), and non-CR after front-line treatment had been connected with poor PFS and Operating-system independently. To conclude, the usage of book agent-based therapy… Continue reading Primary plasma cell leukemia (pPCL) is a rare and aggressive plasma